Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Tab.amiodarone?

See the DrugPatentWatch profile for amiodarone

Amiodarone Tablets (often called “Amiodarone” or “Cordarone”)

What it is A potent anti‑arrhythmic drug (Class III) used to treat serious, life‑threatening heart rhythm problems such as ventricular tachycardia or ventricular fibrillation.
Typical dose • Initial loading dose: 150 mg twice daily for 3 days, then 150 mg once daily for 2 days.
• Maintenance: 125–200 mg daily, often divided into two doses.
• Exact dose depends on the specific arrhythmia, patient weight, and clinical response.
Form 25 mg, 50 mg, 100 mg, 200 mg tablets (often 100‑mg).
How it works Increases the refractory period of cardiac tissue by blocking potassium channels, slows conduction, and prolongs the action potential.
Key benefits Rapid control of life‑threatening arrhythmias, reduction in arrhythmia recurrence, and improved survival in selected patients.
Important side effects Pulmonary toxicity (interstitial pneumonitis, fibrosis) – monitor lungs;
Liver injury – periodic LFTs;
Thyroid dysfunction (hypo- or hyper‑thyroidism) – check TSH;
Corneal deposits – visual changes;
QT prolongation – risk of torsades de pointes;
Skin photosensitivity – avoid sun exposure.
Contraindications • Known hypersensitivity to amiodarone;
• Severe bradycardia, heart block without a pacemaker;
• Recent myocardial infarction (within 48 h) when the risk of torsades is high;
• Significant liver disease;
• Severe pulmonary disease.
Drug interactions Other QT‑prolonging drugs (e.g., sotalol, quinidine, certain antibiotics, antipsychotics) – ↑ risk of torsades de pointes.
CYP3A4 inhibitors/inducers (ketoconazole, clarithromycin, rifampicin) – affect amiodarone metabolism and plasma levels.
Warfarin – increases INR;
Digoxin – can enhance toxicity.
Precautions • Baseline ECG, liver & kidney function tests, chest X‑ray or pulmonary function tests if you have pre‑existing lung disease.
• Re‑check ECG after dose changes or addition of interacting drugs.
• Pregnant women: risk of fetal hypothyroidism and heart defects; use only if benefits outweigh risks.
What to tell the doctor • Any history of heart failure, liver or lung disease, thyroid issues, or vision problems.
• All current medications, supplements, and over‑the‑counter drugs (especially herbal products that might affect CYP enzymes).

Quick “Do‑It” Checklist

  1. Take as prescribed – never skip a dose without consulting your clinician.
  2. Monitor – regular follow‑ups for ECG, liver tests, thyroid panel, and pulmonary status.
  3. Avoid sun – use sunscreen and protective clothing to reduce photosensitivity.
  4. Report – new shortness of breath, chest pain, yellow‑ish skin/eyes, or vision changes immediately.

If you have any specific questions (e.g., about dosing for a particular condition, how it might interact with a medication you’re taking, or what to do if you miss a dose), feel free to ask!



Other Questions About Amiodarone :

Amiodarone generic name? Amiodarone hydrochloride manufacturers? Amiodarone tablet? Generic amiodarone? Indications for amiodarone? Amiodarone price? Amiodarone paten?

AI-Drug Label Prescribing Information Alignment Report

98
98%
Grade A

Excellent

Fully Aligned

Patient Risk: Low

Summary

The AI claim that Pacerone can cause pulmonary toxicity, hepatic toxicity/injury, and can exacerbate/worsen cardiac arrhythmias is directly supported by the provided label warnings/precautions (Sections 5.2, 5.3, and 5.4) with no contradictions.


Category Scores

Warnings
100
Excellent

Accurate Statements

Pacerone can cause pulmonary toxicity.
Supported by Section 5.2 Pulmonary Toxicity (clinical syndrome consistent with pulmonary toxicity; reported rates up to 17%; fatal in about 10%).
Pacerone can cause hepatic toxicity/injury.
Supported by Section 5.3 Hepatic Injury (Pacerone can cause life-threatening hepatic injury; monitoring of liver transaminases and guidance to discontinue or reduce dose if thresholds exceeded).
Pacerone can exacerbate/worsen cardiac arrhythmias.
Supported by Section 5.4 Worsened Arrhythmia (can exacerbate presenting arrhythmia and can cause new ventricular fibrillation/incessant ventricular tachycardia and polymorphic ventricular tachycardia associated with QTc prolongation/TdP).

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
The evaluated statements are warnings present in the label; the response does not omit required safety thresholds or management instructions within the scope of the single evaluated claim.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Fully Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
44
Visibility
48
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

Amiodarone is used to treat certain serious heart rhythm problems (arrhythmias)


Core Claims
  • “Tab amiodarone” usually means an amiodarone tablet
  • Amiodarone is used to treat certain serious heart rhythm problems (arrhythmias)
  • Amiodarone helps stabilize the heart’s electrical activity
  • Dosage depends on the specific condition and the prescriber’s plan
  • It can interact with many drugs and affects organs over time
Differentiators
  • Used for serious heart rhythm problems (arrhythmias)
  • Works by helping stabilize the heart’s electrical activity
  • Can interact with many drugs and affects organs over time
  • Patients are often monitored with follow-up tests because serious side effects can be delayed

Pricing Perception: Not Mentioned